CN103100076B - Medicament for treating eczema - Google Patents

Medicament for treating eczema Download PDF

Info

Publication number
CN103100076B
CN103100076B CN201310071142.2A CN201310071142A CN103100076B CN 103100076 B CN103100076 B CN 103100076B CN 201310071142 A CN201310071142 A CN 201310071142A CN 103100076 B CN103100076 B CN 103100076B
Authority
CN
China
Prior art keywords
parts
herba
fructus
radix
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310071142.2A
Other languages
Chinese (zh)
Other versions
CN103100076A (en
Inventor
隋玉兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310071142.2A priority Critical patent/CN103100076B/en
Publication of CN103100076A publication Critical patent/CN103100076A/en
Application granted granted Critical
Publication of CN103100076B publication Critical patent/CN103100076B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a medicament for treating eczema. The medicament is prepared from the following substances in parts by weight: 5-10 parts of figwort root, 10-20 parts of dried ginger, 20-30 parts of dogwood fruit, 10-20 parts of balloonflower root, 15-25 parts of dahurian angelica root, 5-15 parts of inula flower, 10-30 parts of purslane, 1-15 parts of dutchmanspipe vine, 10-20 parts of ledebouriella root, 15-30 parts of ark shell, 20-30 parts of belleric terminalia fruit, 1-20 parts of morinda root, 1-20 parts of barbat skullcap, 10-25 parts of cogongrass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of natural indigo, 10-20 parts of cardamom, 15-20 parts of herba inulae, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of muskmelon seed, 5-15 parts of climbing fern spore, 1-20 parts of herba ecliptae, 15-25 parts of dahurian rhododendron leaf, 10-20 parts of rhizoma pleionis, 10-30 parts of herba glechomae, 1-15 parts of oyster, 15-20 parts of snake slough and 5-15 parts of lotus seed. According to the medicament for treating eczema, disclosed by the invention, all ingredients are natural materials, the safety performance is better, and the curative effect is clear, so that the medicament is suitable for being clinically popularized in a large scale.

Description

A kind of medicament for the treatment of eczema
Technical field
The present invention relates to Pharmacy department field, relate in particular to a kind of medicament for the treatment of eczema.
Background technology
Eczema is that the inflammatory skin of a kind of common epidermis being caused by multiple internal and external factor and high dermis is sick, it is generally acknowledged with allergy and has certain relation.Its clinical manifestation has the features such as symmetry, exudative, itching skin disease, pleomorphism and recurrent.Eczema is a kind of dermatosis of easy recurrence, treatment needs recurrent medicine dedicated, as the medicine that contains the clean skin composition of health, be also a kind of allergic inflammation dermatoses with erythra multiformity, it is feature that symmetrical, violent pruritus shows effect, easily develops into chronic repeatedly.Can betide any position of any age, in any season, but recur or aggravate the winter of being everlasting, have the tendency of oozing out, the chronic course of disease, easily outbreak repeatedly.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of eczema.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of eczema, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Herba Portulacae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Concha Arcae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Scutellariae Barbatae 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Indigo Naturalis 15-20 part, Fructus Amomi Rotundus 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Semen Melo 10-25 part, Spora Lygodii 5-15 part, Herba Ecliptae 1-20 part, Folium Rhododendri Daurici 15-25 part, Pseudobulbus Cremastrae Seu Pleiones 10-20 part, Herba Glechomae 10-30 part, Concha Ostreae 1-15 part, Periostracum Serpentis 15-20 part and Semen Nelumbinis 5-15 part.
Preferably, the medicament for the treatment of eczema of the present invention is to be made by the material of following weight proportioning: 9 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 24 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 24 parts of the Radixs Angelicae Dahuricae, 11 parts of Flos Inulaes, 27 parts of Herba Portulacaes, 4 parts of Herba Aristolochiaes, 15 parts of Radix Saposhnikoviaes, 24 parts of Concha Arcaes, 23 parts of Fructus Terminaliae Billericaees, 16 parts of Radix Morindae Officinaliss, 15 parts of Herba Scutellariae Barbataes, 21 parts of Rhizoma Imperataes, 27 parts of Fructus Xanthii, 2 parts of Fructus Phyllanthis, 16 parts of Indigo Naturaliss, 14 parts, Fructus Amomi Rotundus, 16 parts of Herba Inulae, 24 parts of Herba Sarcandraes, 13 parts of Herba Clinopodii, 22 parts of Semen Melos, 10 parts of Spora Lygodii, 11 parts of Herba Ecliptaes, 21 parts of Folium Rhododendri Daurici, 13 parts of Pseudobulbus Cremastrae Seu Pleioness, 25 parts of Herba Glechomaes, 5 parts of Concha Ostreaes, 10 parts, 16 parts of Periostracum Serpentiss and Semen Nelumbinis.
More preferably, described medicament is tablet, dispersible tablet, capsule or ointment.
Whole compositions of the medicament for the treatment of eczema of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Below by embodiment, further illustrate the present invention.It should be understood that embodiments of the invention are for the present invention rather than limitation of the present invention are described.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percent otherwise in the present invention is percetage by weight.
Embodiment ointment of the present invention
Take 9 grams of Radix Scrophulariaes, 13 grams of Rhizoma Zingiberiss, 24 grams of Fructus Corni, 15 grams of Radix Platycodoniss, 24 grams of the Radixs Angelicae Dahuricae, 11 grams of Flos Inulaes, 27 grams of Herba Portulacaes, 4 grams of Herba Aristolochiaes, 15 grams of Radix Saposhnikoviaes, 24 grams of Concha Arcaes, 23 grams of Fructus Terminaliae Billericaees, 16 grams of Radix Morindae Officinaliss, 15 grams of Herba Scutellariae Barbataes, 21 grams of Rhizoma Imperataes, 27 grams of Fructus Xanthii, 2 grams of Fructus Phyllanthis, 16 grams of Indigo Naturaliss, 14 grams, Fructus Amomi Rotundus, 16 grams of Herba Inulae, 24 grams of Herba Sarcandraes, 13 grams of Herba Clinopodii, 22 grams of Semen Melos, 10 grams of Spora Lygodii, 11 grams of Herba Ecliptaes, 21 grams of Folium Rhododendri Daurici, 13 grams of Pseudobulbus Cremastrae Seu Pleioness, 25 grams of Herba Glechomaes, 5 grams of Concha Ostreaes, 10 grams, 16 grams of Periostracum Serpentiss and Semen Nelumbinis, pulverize, cross 80 mesh sieves, micronization is pulverized, cross 100 mesh sieves, mix homogeneously.To adding 340 grams, 200 grams of liquid paraffin and vaseline in the above-mentioned powder mixing, be stirred to and be even paste, obtain.
Experimental example
30 examples all meet the diagnostic criteria of < < clinical dermatology > > eczema (Zhao debates. clinical dermatology [M]. the 3rd edition. Nanjing: Jiangsu science tech publishing house, 2001.605.).Man's 19 examples, female's 11 examples; Age 27-74 year, average 47.6 years old; The course of disease 3 months-10 years, average 1.5 years; Forethiga eczema 6 examples, the back of the hand portion eczema 4 examples, buttocks eczema person 1 example, huckle eczema person 7 examples, legs eczema person 9 examples, dorsal portion eczema 3 examples.Show as skin lesion and be pleomorphism, be apt to occur in face, hands, foot, shank, visible red mottle or dark red mottle, pimple, vesicle, ooze out, rotten to the corn etc., visible pustule, pus crusts during secondary infection, acute pruritus, accompanies vexed, thirsty, constipation, red tongue yellow fur, slippery and rapid pulse.
Use the ointment of preparation in embodiment 1 to treat for above-mentioned patient, to be evenly applied to affected part, be as the criterion, one day twice, 20 grams of each every place coatings, seven days were a course for the treatment of.
Criterion of therapeutical effect
Recovery from illness: erythra all disappears, and only leaves over pigmentation, pruritus transference cure, follows up a case by regular visits to not recurrence in 1 year.Effective: erythra obviously disappears or major part disappears, and pruritus obviously alleviates, even in 1 year have recurrence, but symptom is slight, and skin lesion is front minimizing.Effective: erythra partly disappears, symptom takes a turn for the better, and has slight pruritus.Invalid: erythra is without disappearing or symptom increases the weight of.
30 routine patients are after treating 1 course for the treatment of, and the erythra of all patients all disappears, and only leave over pigmentation, pruritus transference cure.And follow up a case by regular visits to not recurrence in 1 year.

Claims (2)

1. an ointment for the treatment of eczema, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Herba Portulacae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Concha Arcae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Scutellariae Barbatae 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Indigo Naturalis 15-20 part, Fructus Amomi Rotundus 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Semen Melo 10-25 part, Spora Lygodii 5-15 part, Herba Ecliptae 1-20 part, Folium Rhododendri Daurici 15-25 part, Pseudobulbus Cremastrae Seu Pleiones 10-20 part, Herba Glechomae 10-30 part, Concha Ostreae 1-15 part, Periostracum Serpentis 15-20 part and Semen Nelumbinis 5-15 part.
2. the ointment for the treatment of eczema according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 9 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 24 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 24 parts of the Radixs Angelicae Dahuricae, 11 parts of Flos Inulaes, 27 parts of Herba Portulacaes, 4 parts of Herba Aristolochiaes, 15 parts of Radix Saposhnikoviaes, 24 parts of Concha Arcaes, 23 parts of Fructus Terminaliae Billericaees, 16 parts of Radix Morindae Officinaliss, 15 parts of Herba Scutellariae Barbataes, 21 parts of Rhizoma Imperataes, 27 parts of Fructus Xanthii, 2 parts of Fructus Phyllanthis, 16 parts of Indigo Naturaliss, 14 parts, Fructus Amomi Rotundus, 16 parts of Herba Inulae, 24 parts of Herba Sarcandraes, 13 parts of Herba Clinopodii, 22 parts of Semen Melos, 10 parts of Spora Lygodii, 11 parts of Herba Ecliptaes, 21 parts of Folium Rhododendri Daurici, 13 parts of Pseudobulbus Cremastrae Seu Pleioness, 25 parts of Herba Glechomaes, 5 parts of Concha Ostreaes, 10 parts, 16 parts of Periostracum Serpentiss and Semen Nelumbinis.
CN201310071142.2A 2013-03-07 2013-03-07 Medicament for treating eczema Expired - Fee Related CN103100076B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310071142.2A CN103100076B (en) 2013-03-07 2013-03-07 Medicament for treating eczema

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310071142.2A CN103100076B (en) 2013-03-07 2013-03-07 Medicament for treating eczema

Publications (2)

Publication Number Publication Date
CN103100076A CN103100076A (en) 2013-05-15
CN103100076B true CN103100076B (en) 2014-03-26

Family

ID=48308488

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310071142.2A Expired - Fee Related CN103100076B (en) 2013-03-07 2013-03-07 Medicament for treating eczema

Country Status (1)

Country Link
CN (1) CN103100076B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266486A (en) * 2011-07-27 2011-12-07 陈忠和 Medicament for desensitizing, eliminating rashes and removing sores

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101716291B (en) * 2009-11-17 2011-05-04 王茂基 Oral traditional Chinese medicine for treating skin diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266486A (en) * 2011-07-27 2011-12-07 陈忠和 Medicament for desensitizing, eliminating rashes and removing sores

Also Published As

Publication number Publication date
CN103100076A (en) 2013-05-15

Similar Documents

Publication Publication Date Title
CN102205078B (en) High-efficiency compound lightyellow sophora root lotion and preparation method thereof
CN103341145B (en) Traditional Chinese medicine for treating psoriasis and preparation method thereof
CN103100075B (en) Medicament for treating eczema
CN102872241A (en) Traditional Chinese medicinal composition for treating inflammatory dermatosis and preparation thereof
WO2018137319A1 (en) Application of sarcococca vagans, chinese medicinal ointment for treating skin disease, preparation method and application thereof
CN102824477A (en) Traditional Chinese medicine paste for treating dermatosis
CN103100076B (en) Medicament for treating eczema
CN101843861B (en) Chinese medicinal composition for treating tonsillitis
CN102327460B (en) Medicament for treating eczema
CN103877250B (en) A kind ofly treat Chinese medicine composition of skin eczema pruritus and preparation method thereof
CN101612203B (en) Traditional Chinese medicine composition used for treating pointed condyloma and application thereof
CN102935218B (en) Traditional Chinese medicine composition for treating decubitus in clinical care
CN102940794B (en) Traditional Chinese medicine for treating eczema and preparation method thereof
CN101780179B (en) Multifunctional plant composition and application thereof as well as multifunctional plant extractive composition, application and antibiotic composition thereof
CN102579789B (en) Medicine for treating eczema
CN101708294B (en) Medicinal composition for treating dermatosis chronic disease and preparation method thereof
CN102716217B (en) Medicine composition for treating acne
CN106728455A (en) A kind of externally used Mongolian medicine composition for treating dermatitis, eczema and preparation method thereof
CN104984231A (en) Traditional Chinese medicine for treating malaria
CN105288517A (en) Traditional Chinese medicine lotion for treating anal fissure
CN103142960B (en) Medicament for treating skin diseases
CN104225343A (en) Chinese herbal preparation for treating urinary tract infection and preparation method thereof
CN103920143B (en) Chinese lobelia spray for resisting oral helicobacter pylori
CN102988805B (en) Traditional Chinese medicine composition for treating allergic purpura
CN103393729A (en) Stranguria relieving and calculus eliminating powder

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140326

Termination date: 20150307

EXPY Termination of patent right or utility model